Contact
Please use this form to send email to PR contact of this press release:
Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
TO:
Please use this form to send email to PR contact of this press release:
Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
TO: